OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2023-03-31-accounts

Charity Registration Number 1189246

British Psoriatic Arthritis Consortium

Report and Accounts

31 March 2023

British Psoriatic Arthritis Consortium

Report and accounts for the year ended 31 March 2023

Contents

Page
Charity information 1
Members' Annual Report 1
Statement of Members' responsibilities 4
Independent Accountant's Report 7
Statement of Financial Activities 8
Balance sheet 10
Notes to the accounts 11

British Psoriatic Arthritis Consortium

Members' Annual Report for the year ended 31 March 2023

The Members present their Report and Accounts for the year ended 31 March 2023.

Reference and administrative details

The charity name

The legal name of the charity is:- British Psoriatic Arthritis Consortium.

The charity is also known by its operating name, Brit-PACT.

The charity's areas operation and UK charitable registration

The charity is registered in England & Wales with the Charity Commission in England & Wales (CCEW) with charity number 1189246.

The charity does not operate in any overseas jurisdictions.

Legal structure of the charity

The charity is constituted as a Charitable Incorporated Organisation (CIO) in England & Wales. The governing document of the charity is the constitution of the CIO as approved by the Charity Commission in England & Wales (CCEW) .

The governing document is dated 20 April 2020 There are no restrictions in the governing documents on the operation of the Charity or on its investment powers other than those imposed by Charity Law.

The trustees are all individuals.

The principal operating address and website of the charity are:-

Department D1, Wolfson Building

Royal United Hospital, Combe Park

Bath, BA1 3NG

www.britpact.org.uk

The Members in office on the date the report was approved were:-

A Parkinson (resigned 25/11/2022)

B Kirkham (resigned 25/11/2022) D Jadon J Packham M Turfrey N Gullick H Jethwa P Helliwell L Coates

O FitzGerald (resigned 25/11/2022)

S Siebert (resigned 25/11/2022)

W Tillet T Gudu (appointed 25/11/2022) C Allen (appointed 25/11/2022) P Ho (appointed 25/11/2022) A Kelly (appointed 25/11/2022) S Mukherjee (appointed 26/11/2021) L Hailey (appointed 26/11/2021)

The following persons served as Members during the year ended 31 March 2023 :-

The members who served as a member in the reporting period were as shown above, and there were no changes during the year, or in the period between the year end and the approval of the accounts.

1

British Psoriatic Arthritis Consortium

Members' Annual Report for the year ended 31 March 2023

Objects and activities of the charity

The purposes of the charity as set out in its governing document

The object of the CIO is to relieve sickness and to preserve and protect good health for the public benefit by promoting medical knowledge, and excellence through education and research with particular reference to the diseases of psoriasis and psoriatic arthritis.

The main activities undertaken in relation to those purposes during the year

In this financial year, Brit-PACT continues to progress in its mission to support education and research into psoriatic arthritis (PsA) in the UK.

We held a successful annual meeting in hybrid format in November 2022 which was arranged by Dr Nicola Gullick and Dr Jon Packham, and chaired by Dr Nicola Gullick and Dr William Tillett. This had attendees (32 in person and 30 online). Meeting highlights included a presentation on Ethnicity, Diversity and Inclusion by Dr Ade Adebajo, a patient-led session on patient experience of both newly diagnosed and more established psoriatic arthritis, abstract prize-winning presentations by rheumatology fellows, Brit-PACT project updates and an update from the PROMPT study investigators.

We launched a pilot research grant scheme at the Annual meeting in 2022. Extremely competitive applications were received and two pilot grants were awarded to Academic Clinical Fellows in Oxford and Manchester in April 2023. All grants submitted were asked to include at least one of the ‘Top 10’ items identified in the James Lind Priority Setting Partnership, which had been funded previously by BritPACT. Early results from these pilot projects will be reported at the Annual Meeting in November 2023. We have continued to support other research with external funding. This includes the SEQUENCE study, which was launched in 2022. Data is now being collected from a number of sites across the UK. BritPACT continues to provide support and updates to the British Society for Rheumatology on its activities and provides support to subcommittees of the BSR such as recommendations for biologic use in psoriatic arthritis.

The main activities undertaken during the year to further the charity's purpose for the public benefit.

As in previous years the main activities of BritPACT during the last year were educational meetings and the launch of pilot research grants and BritPACT-led research projects, both of which fulfilled the purpose of the charity and will be of benefit the charity’s beneficiaries. Members of the Executive Committee and took part in an external project to create consensus recommendations for diagnosis, assessment and management of psoriatic arthritis, including its comorbidities. These recommendations also were reviewed by representatives from the BritPACT patient group. These were presented at an international rheumatology conference in June 2023 and a publication is in progress.

The trustees have had regard to the Charity Commission's guidance on public benefit in managing the activities of the charity.

2

British Psoriatic Arthritis Consortium

Members' Annual Report for the year ended 31 March 2023

The main achievements and performance of the charity during the year

1.Psoriatic Arthritis Education for Health Care Professionals

Brit-PACT continues to conduct educational meetings for rheumatology health care professionals and seeks to grow membership with a wider spectrum of HCPs, including dermatologists and allied health professionals.

2.Funding and supporting Psoriatic Arthritis Research

BritPACT has funded 2 pilot research projects, supporting small projects which aim to answer research questions relevant to patients with PsA. These were awarded to Dr Dylan McGagh (University of Oxford) and Dr Ryan Hum (University of Manchester).

External funding was previously successfully sought for the SEQUENCE study which is now collecting data on use of high cost treatments for Psoriatic Arthritis in Rheumatology Departments across the UK, with high engagement from the general BritPACT membership

3.Sharing patient perspective on living with psoriatic disease.

•The patient partners continue to share the patient perspective with Clinicians & HCPs and collaborate with other organisations to inform research direction. Two of the patient members of the Steering Committee presented at the annual meeting. The patient partners have started work on a new patient led e-survey investigating the patient experience of non-pharmacological therapies. The patient group has also advised on Psoriatic Arthritis consensus recommendations and engaged with other activities including surveys, workshops and assisting with grant applications as well as to a number of other engagement/involvement opportunities. The patient group has also contributed to the iPROLEPSIS advisory group: The EU-unded iPROLEPSIS project aims to improve early detection of PsA symptoms and reduce diagnostic delay. Finally the patient partner group has also contributed to Trailblazers, where there are opportunities for patients to engage such as completing a survey, helping with grant applications, and participation in workshops.

The difference the charity's performance during the year has made to the beneficiaries of the charity

Recognised by NIHR and HTA the James Lind PSP has prioritised research themes for both researchers and funders and will focus direction of research for the future, including those projects supported or funded by BritPACT. BritPACT educational updates and virtual meetings provide educational opportunities for rheumatologists in training and rheumatology teams in the UK. The BritPACT patient partners also benefit from these educational activities as well as providing support to others both in person and electronically.

The degree to which the achievements and performance during the year have benefited wider society.

The results of the PsA James Lind Priority Setting Partnership “Top 10” is now being used to feed into grant proposals so that research prioritises area important to clinicians, patients and carers. The JLPSP will continue to help both researchers and funders to prioritise research in this area and help prevent the impact of psoriatic arthritis on patients, carers, and employers, as well as to raise the profile of psoriatic arthritis from a societal point of view.

The patient partners provide an alternative perspective to psoriatic arthritis and help professionals and patients alike to achieve better, more holistic, care.

3

British Psoriatic Arthritis Consortium

Members' Annual Report for the year ended 31 March 2023

Structure, governance and management of the charity

The methods used to recruit and appoint new charity trustees.

The BritPACT constitution incorporates elections for major Executive committee positions. The Executive Committee (trustees) includes rheumatologists in training, allied health professionals and patient partners. In line with the constitution of the Charity nominations are sought annually for new Executive committee members as vacancies become available, and voting is by a single vote of all members, the majority vote taken as the definitive result. In this calendar year there have been 3 retirements from the Executive (Prof Oliver Fitzgerald, Prof Bruce Kirkham, Prof Stefan Siebert) and 2 new medical members elected (Dr Pauline Ho & Dr Tania Gudu) In addition, two new patient partner representatives were elected (Clare Allen & Andy Kelly), to replace Andrew Parkinson. Prof Laura Coates stepped down as Chair of the Executive Committee and was replaced by Dr Nicola Gullick.

Unity Trust Bank, 4 Brindley Place, Birmingham B1 2JB

Bankers Solicitors Stone King LLP, 13 Queen Square, Bath BA1 2HJ Accountants DR Hicks, 107 Penn Hill Road, Bath BA1 3RU

Financial review

The charity's financial position at the end of the year ended 31 March 2023

The financial position of the charity at 31 March 2023 and comparatives for the prior period, as more fully detailed in the accounts, can be summarised as follows:-

Restricted Revenue Funds
Total Funds
Unrestricted Revenue Funds available for the
general purposes of the charity
Net income		 2023
£
79,184
131,938
127,748
259,686		 2022
£
70,123
94,128
86,374
180,502

Financial review of the position at the reporting date 31 March 2023

The members consider the financial performance by the charity during the year to have been satisfactory.

Policies on reserves

The board of trustees agree to run the charity with reserves sufficient to meet expenses for approximately one year.

Availability and adequacy of assets of each of the funds

The board of trustees is satisfied that the charity's assets in each fund are available and adequate to fulfil its obligations in respect of each fund.

4

British Psoriatic Arthritis Consortium

Members' Annual Report for the year ended 31 March 2023

Details of The Independent Examiner

Dione Hicks

Member of the Institute of Chartered Accountants in England & Wales 107 Penn Hill Road

Bath

BA1 3RU

Statement of Members' Responsibilities

The charity's trustees are responsible for the preparation of the accounts in accordance with the terms of the Charities Act 2011 and the Charities (Accounts and Reports) Regulations 2008. Notwithstanding the explicit requirement in the extant statutory regulations,the Charities (Accounts and Reports) Regulations 2008, to prepare the financial statements in accordance with the SORP 2005, in view of the fact that the SORP 2005 has been withdrawn, the Members determined to interpret this responsibility as requiring them to follow current best practice and prepare the accounts according to the FRS 102 SORP (Statement of Recommended Practice for Accounting and Reporting by Charities) 2015, (as amended by the Bulletin issued in October 2018 and applicable to all accounting periods beginning on or after 1st January 2019), (The SORP), .

In particular, charity law requires the Members, if they prepare accounts on an accruals basis, to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the charity as at the end of the financial year and of the surplus or deficit of the charity. In preparing those financial statements the Members are required to :-

recommended practice have been followed, subject to any material

departures disclosed and explained in the financial statements;

The law requires that the trustees must not approve the accounts unless they are satisfied that they give a true and fair view of the state of affairs of the charity and of the surplus or deficit of the charity for the year.

The Members are also responsible for maintaining adequate accounting records which disclose with reasonable accuracy at any time the financial position of the charity and which are sufficient to show and explain the charity's transactions and enable them to ensure that the financial statements comply with regulations made under the Charities Act 2011. They are also responsible for safeguarding the assets of the charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

The Members are also responsible for the contents of the Members' report, and the statutory responsibility of the Independent Examiner in relation to the Members' report is limited to examining the report and ensuring that , on the face of the report, there are no material inconsistencies with the figures disclosed in the financial statements.

5

British Psoriatic Arthritis Consortium

Members' Annual Report for the year ended 31 March 2023

This report was approved by the board of trustees on 26 November 2023.

P Helliwell Trustee

6

British Psoriatic Arthritis Consortium

Report of the Independent Examiner to the Members of the charity on the accounts for the year ended 31 March 2023

I report to the Members on my examination of the financial statements of the charity on pages 9 to 18 for the year ended 31 March 2023 which have been prepared in accordance with the Charities Act 2011 (the Act) and with the Financial Reporting Standard 102, (effective 1st January 2016) as modified by FRS 102 SORP (Statement of Recommended Practice for Accounting and Reporting by Charities) 2015, (as amended by the Bulletin issued in October 2018 and applicable to all accounting periods beginning on or after 1st January 2019), (The SORP), published by the Charity Commission in England & Wales (CCEW) , and under the historical cost convention and the accounting policies set out on page 11.

Respective responsibilities of the Members and the Independent Examiner and the basis of the report

As described on page 4, you, the charity's Members, are responsible for the preparation of the financial statements in accordance with the Charities Act 2011 and all other applicable law and with United Kingdom Generally Accepted Accounting Practice, applicable to smaller entities, and for being satisfied that the financial statements give a true and fair view.

The Members consider that the audit requirement of Section 144(1) of the Charities Act 2011 (the Act) does not apply, and that there is no requirement in the Governing Document for the conducting of an audit. As a consequence, the Members have elected that the financial statements be subject to independent examination.

Having satisfied myself that the financial statements are not required to be audited under any legal provision, or otherwise, and are eligible for independent examination, it is my responsibility to:-

a) examine the financial statements of the charity under Section 145 of the Act;

b) follow the applicable procedures in the Directions given by the Charity Commission under section 145(5)(b) of the Act.

Basis of Independent Examiner's Statement and scope of work undertaken

I report in respect of my examination of the charity's financial statements carried out under s145 of the Act. In carrying out my examination, I have followed all the applicable Directions given by the Charity Commission under section 145(5)(b) of the Act setting out the duties of an independent examiner in relation to the conducting of an independent examination. An independent examination includes a review of the accounting records kept by the charity and of the accounting systems employed by the charity and a comparison of the financial statements presented with those records. It also includes consideration of any unusual items or disclosures in the financial statements, and seeking explanations from you, as Members, concerning such matters. The purpose of the examination is to establish as far as possible that there have been no breaches of charity legislation and that, on a test basis of evidence relevant to the amounts and disclosures made, the financial statements comply with the SORP.

The procedures undertaken do not provide all the evidence that would be required in an audit, and information supplied by the Members in the course of the examination is not subjected to audit tests or enquiries and does not cover all the matters that an auditor would consider in arriving at an opinion. The planning and conduct of an audit goes beyond the limited assurance that an independent examination can provide

Consequently, I do not express an audit opinion on the view given by the financial statements, and in particular, I express no opinion as to whether the financial statements give a true and fair view of the affairs of the charity, and my report is limited to the matters set out in the statement below.

I planned and performed my examination so as to satisfy myself that the objectives of the independent examination are achieved and before finalising the report I obtained written assurances from the Members of all material matters.

Independent Examiner's Statement, Report and Opinion

Subject to the limitations upon the scope of my work as detailed above, I have completed my examination: and can confirm that:-

7

British Psoriatic Arthritis Consortium

This is a report in respect of an examination carried out under 145 of the Act and in accordance with Directions given by the Charity Commission under section 145(5)(b) of the Act which may be applicable;

and that no material matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:-

accounting records were not kept in respect of the charity as required by with Section 130 of The Charities Act 2011;

the financial statements do not accord with those records; or

the financial statements do not comply with the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the accounts give a 'true and fair' view, which is not a matter considered as part of an independent examination;

have not been prepared in accordance with the methods and principles set out in the FRS 102 SORP (Statement of Recommended Practice for Accounting and Reporting by Charities) 2015, (as amended by the Bulletin issued in October 2018 and applicable to all accounting periods beginning on or after 1st January 2019), (The SORP).

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the financial statements to be reached.

Signed:-

Dione Hicks - Independent Examiner

Chartered Accountants 107 Penn Hill Road Bath BA1 3RU

This report was signed on 26 November 2023

8

British Psoriatic Arthritis Consortium

Statement of Financial Activities for the year ended 31 March 2023

Current year
Unrestricted
Funds
2023
£
Income & Endowments from:
Donations & Legacies
A1
60,256
Investments
A4
99
Total income
A
60,355
Expenditure on:
Charitable activities
B2
22,545
Total expenditure
B
22,545
Net income for the year
37,810
Net income after transfers
A-B-C
37,810
37,810
Reconciliation of funds:-
E
Total funds brought forward
94,128
Total funds carried forward
131,938
SORP
Ref
Net movement in funds		 Current year
Restricted
Funds
2023
£
86,374
-
86,374
45,000
45,000
41,374
41,374
41,374
86,374
127,748		 Current year
Total Funds
2023
£
146,630
99
146,729
67,545
67,545
79,184
79,184
79,184
180,502
259,686		 Prior Year
Total Funds
2022
£
116,702
-
116,702
46,579
46,579
70,123
70,123
70,123
110,379
180,502

The 'SORP Ref' indicated above is the classification of income set out in the formal SORP documents. As required by paragraph 4.60 of the SORP, the brought forward and carried forward funds above have been agreed to the Balance Sheet.

A separate Statement of Total Recognised Gains and Losses is not required as this statement includes all recognised gains and losses.

All the prior year transactions were unrestricted items, and no further analysis is required

All activities derive from continuing operations

The notes attached on pages 11 to 18 form an integral part of these accounts.

9

British Psoriatic Arthritis Consortium

Balance Sheet as at 31 March 2023

SORP
Note Ref 2023 2022
£ £
Current assets B
Debtors 6 B2 853 -
Cash at bank and in hand B4 262,116 189,093
Total current assets 262,969 189,093
Creditors: amounts falling due within
one year 7 C1 (3,283) (8,591)
Net current assets 259,686 180,502
The total net assets of the charity 259,686 180,502
The total net assets of the charity are funded by the funds of the charity, as follows:-
Restricted funds
Restricted Revenue Funds 11 D2 127,748 86,374
127,748 86,374
Unrestricted Funds
Unrestricted Revenue Funds 11 D3 131,938 94,128
131,938 94,128
Designated Funds
Total charity funds 259,686 180,502

The 'SORP Ref' indicated above is the classification of Balance Sheet items as set out in the formal SORP documents. As required by paragraph 4.60 of the SORP, the brought forward and carried forward funds above have been agreed to the SOFA..

The Members acknowledge their responsibilities for complying with the requirements of charity legislation with res

The charity is subject to Independent Examination under charity legislation, and the report of the Independent Examiner is on page 8.

The Members are satisfied that, although the charity is not registered under the Companies Acts, if it were so registered, it would be eligible to prepare accounts in accordance with the provisions in Part 15 of the Companies Act 2006. applicable to companies subject to the small companies regime.

P Helliwell

Trustee

Approved by the board of trustees on 26 November 2023

The notes attached on pages 11 to 18 form an integral part of these accounts.

10

British Psoriatic Arthritis Consortium

Notes to the Accounts for the year ended 31 March 2023

1 Accounting policies

Policies relating to the production of the accounts.

Basis of preparation and accounting convention

The accounts have been prepared on the accruals basis, under the historical cost convention, and in accordance with the Financial Reporting Standard 102, (effective 1st January 2016) and 'FRS 102 SORP (Statement of Recommended Practice for Accounting and Reporting by Charities) 2015, (as amended by the Bulletin issued in October 2018 and applicable to all accounting periods beginning on or after 1st January 2019), (The SORP), published by the Charity Commission in England & Wales (CCEW) , effective January 2016, , and in accordance with all applicable law in the charity's jurisdiction of registration, except that the charity has prepared the financial statements in accordance with the FRS 102 SORP (Statement of Recommended Practice for Accounting and Reporting by Charities) 2015, (as amended by the Bulletin issued in October 2018 and applicable to all accounting periods beginning on or after 1st January 2019), (The SORP), in preference to the previous SORP, the SORP 2005, which has been withdrawn, notwithstanding the fact that the extant statutory regulations, the Charities (Accounts and Reports) Regulations 2008 refer explicitly to the SORP 2005. This has been done to accord with current best practice.

Going Concern

Under 3.38 and to comply with 3.14, if there are no uncertainties about going concern this MUST be stated. Under 3.39, if there are uncertainties details must be given. Enter text here to comply

Suggested normal text (whioch may require modification to meet the circumstances):-

The charitable activities are entirely dependent on continuing grant aid and voluntary donations as well as trading revenues. As a consequence, the going concern basis is dependent on the future flow of these uncertain funding streams. Accordingly, the Trustees have obtained forecasts and, after reviewing the financial forecasts for future periods to 31 March 2021, the Trustees are satisfied that, at the time of approving the financial statements, it is appropriate to adopt the going concern basis in preparing the financial statements. Other than these matters, the Trustees are not aware of any material uncertainites about the charity's ability to continue as a going concern.

Risks and future assumptions

The charity is a public benefit entity.

Policies relating to categories of income and income recognition.

Nature of income

Gross income represents the value, net of value added tax and discounts, of goods provided to customers and work carried out in respect of services provided to customers.

Categories of Income

Income is categorised as income from exchange transactions (contract income) and income from non-exchange transactions (gifts), investment income and other income.

Income from exchange transactions is received by the charity for goods or services supplied under contract or where entitlement is subject to fulfilling performance related conditions. The income the charity receives is approximately equal in value to the goods or services supplied by the charity to the purchaser.

Income from a non-exchange transaction is where the charity receives value from the donor without providing equal value in exchange, and includes donations of money, goods and services freely given without giving equal value in exchange.

11

British Psoriatic Arthritis Consortium

Notes to the Accounts for the year ended 31 March 2023

Income recognition

Income, whether from exchange or non exchange transactions, is recognised in the statement of financial activities (SOFA) on a receivable basis, when a transaction or other event results in an increase in the charity’s assets or a reduction in its liabilities and only when the charity has legal entitlement, the income is probable and can be measured reliably.

Dividends are accrued when the shareholder’s right to receive payment is established.

Income subject to terms and conditions which must be met before the charity is entitled to the resources is not recognised until the conditions have been met.

All income is accounted for gross, before deducting any related fees or costs.

Policies relating to expenditure on goods and services provided to the charity.

Recognition of liabilities and expenditure

A liability, and the related expenditure, is recognised when a legal or constructive obligation exists as a result of a past event, and when it is more likely than not that a transfer of economic benefits will be required in settlement, and when the amount of the obligation can be measured or reliably estimated..

Liabilities arising from future funding commitments and constructive obligations, including performance related grants, where the timing or the amount of the future expenditure required to settle the obligation are uncertain, give rise to a provision in the accounts, which is reviewed at the accounting year end. The provision is increased to reflect any increases in liabilities, and is decreased by the utilisation of any provision within the period, and reversed if any provision is no longer required. These movements are charged or credited to the respective funds and activities to which the provision relates.

Policies relating to assets, liabilities and provisions and other matters.

Debtors

Debtors are measured at their recoverable amounts at the balance sheet date.

Creditors and provisions

Creditors and provisions are measured at their recoverable amounts at the balance sheet date.

Cash and bank balances

Cash held by the charity is included at the amount actually held and counted at the year end. Bank balances, whether in credit or overdrawn, are shown at the amounts properly reconciled to the bank statements.

Fund Accounting

Unrestricted funds are available for use at the discretion of the trustees in furtherance of the general objectives of the charity.

There are no designated funds.

Restricted funds are subjected to restrictions on their expenditure imposed by the donor or through the terms of an appeal or as implied by law.

There are no endowment funds.

12

British Psoriatic Arthritis Consortium

Notes to the Accounts for the year ended 31 March 2023

2 Liability to taxation

The Trustees consider that the charity satisfies the tests set out in Paragraph 1 Schedule 6 of the Finance Act 2010 for UK corporation tax purposes. Accordingly, the Charity is potentially exempt from taxation in respect of income or capital gains received within categories covered by chapter 3 part 11 of the Corporation Tax Act 2010 or Section 256 of the Taxation of Chargeable Gains Act 1992, to the extent that such income or gains are applied exclusively on the specific charitable objects of the charity and for no other purpose. Value Added Tax is not recoverable by the charity, and is therefore included in the relevant costs in the Statement of Financial Activities.

3 Winding up or dissolution of the charity

If upon winding up or dissolution of the charity there remain any assets, after the satisfaction of all debts and liabilities, the assets represented by the accumulated fund shall be transferred to some other charitable body or bodies having similar objects to the charity.

4 Significance of financial instruments to the charity's position

There are no significant implications of financial instruments to the Charity's positon.

5 Remuneration and payments to Trustees and persons connected with them

No trustees or persons connected with them received any remuneration from the charity, or any related entity.

6 Debtors

Prepayments and accrued income
7 Creditors: amounts falling due within one year
Trade creditors
8 Income and Expenditure account summary
At 1 April 2022
Surplus for the year
At 31 March 2023		 2023
2022
£
£
853
-
2023
2022
£
£
3,283
8,591
2023
2022
£
£
180,502
110,379
79,184
70,123
259,686
180,502

9 No related party transactions

There were no transactions with related parties in the year.

13

British Psoriatic Arthritis Consortium

Notes to the Accounts for the year ended 31 March 2023

10 Particulars of how particular funds are represented by assets and liabilities

At 31 March 2023
Current Assets
Current Liabilities
At 1 April 2022
Current Assets
Current Liabilities		 Unrestricted
funds
£
135,221
(3,283)		 Designated
funds
£
-		 Restricted
Total
Total
funds
Funds
Funds
£
£
£
127,748
262,969
262,969
-
(3,283)
(3,283)
131,938 - 127,748
259,686
259,686
Unrestricted
funds
£
102,719
(8,591)		 Designated
funds
£
-
-		 Restricted
Total
Total
funds
Funds
Funds
£
£
£
86,374
189,093
189,093
-
(8,591)
(8,591)
94,128 - 86,374
180,502
180,502

11 Change in total funds over the year as shown in Note 10 , analysed by individual funds

Unrestricted and designated funds:-
Unrestricted Revenue Funds
Total unrestricted and designated funds
Restricted funds:-
Sequence Project
Total restricted funds
Total charity funds		 Funds
brought
forward from
2022
£
94,128		 Movement
in funds in
2023
See Note 12
£
37,810		 Funds
carried
forward to
2024
£
£
£
-
131,938
131,938
Funds
carried
forward to
2024
Transfers
between
funds in
2023
94,128 37,810 -
131,938
131,938
86,374 41,374 -
127,748
127,748
86,374 41,374 -
127,748
127,748
180,502 79,184 -
259,686
259,686

14

British Psoriatic Arthritis Consortium

Notes to the Accounts for the year ended 31 March 2023

12 Analysis of movements in funds over the year as shown in Note 11

Unrestricted and designated funds:-
Unrestricted Revenue Funds
Restricted funds:-
Sequence Project		 Income
2023
£
60,355
86,374		 Expenditure
2023
£
(22,545)
(45,000)		 Other
Gains &
Movement
Movement
Losses
in funds
in funds
2023
2023
2023
£
£
£
-
37,810
37,810
-
41,374
41,374
146,729 (67,545) -
79,184
79,184

13 The purposes for which the funds as detailed in note 11 are held by the charity Unrestricted and designated funds:-

Unrestricted Revenue Funds

These funds are held for the meeting the objectives of the charity, and to provide reserves for future activities, and , subject to charity legislation, are free from all restrictions on their use.

Designated Revenue Funds

There are no such funds held by the Charity.

Restricted funds:-

Restricted Revenue Funds

Funds specific for this pupose.

14 Ultimate controlling party

The charity is under the control of its legal members.

If the CIO is wound up, the members of the CIO have no liability to contribute to its assets and no personal responsibility for settling its debts and liabilities.

15

British Psoriatic Arthritis Consortium

Detailed analysis of income and expenditure for the year ended 31 March 2023 as required by the SORP 2015

This analysis is classsified by conventional nominal descriptions and not by activity.

15 Donations, Grants and Legacies

Donations, Grants and Legacies
Donations and gifts from individuals
Small donations individually less than £1000
Total private sector revenue grants
UCB
Janssen Claig Ltd
Revenue grants and donations from
non public bodies
Pfizer
Eli Lilly
Total donations and gifts from
individuals		 Current year
Unrestricted
Funds
2023
£
256		 Current year
Restricted
Funds
2023
£
-
-
Current year
Restricted
Funds
2023
£
-
-
43,187
43,187
86,374		 Current year
Total Funds
2023
£
256
256
Current year
Total Funds
2023
£
-
-
43,187
43,187
86,374		 Prior Year
Total Funds
2022
£
2,828
256 2,828
Current year
Unrestricted
Funds
2023
£
-
-
-
-		 Prior Year
Total Funds
2022
£
43,187
43,187
-
-
- 86,374

Revenue grants and donations from non public bodies (Include Gift Aid donations from subsidiaries) - Prior Year analysis

Total Donations, Grants and Legacies
Total Donations, Grants and
Legacies
A1
Sponsorships
Total sponsorship income		 Prior Year
Unrestricted
Funds
2022
£
Current year
Unrestricted
Funds
2023
£
60,000		 Prior Year
Restricted
Funds
2022
£
Current year
Restricted
Funds
2023
£
-
-		 Prior Year
Total Funds
2022
£
Current year
Total Funds
2023
£
60,000
60,000		 Prior Year
Total Funds
2022
£
27,500
60,000 27,500
60,256 86,374 146,630 116,702

16

British Psoriatic Arthritis Consortium

Detailed analysis of income and expenditure for the year ended 31 March 2023 as required by the SORP 2015

16 Investment income

16 Investment income
Current year
Unrestricted
Funds
2023
£
Bank Interest Receivable
99
Total investment income
A4
99
17 Expenditure on charitable activities - Direct spending
Current year
Current Year
Unrestricted
Funds
2023
£
4,328
600
-
2,242
9,542
-
Total direct spending
B2a
16,712
18
Current year
Current Year
Unrestricted
Funds
2023
£
Premises Expenses
1,850
Administrative overheads
216
138
150
608
293
10
830
-
Financial costs
96
Total support costs
4,191
Bank charges
Sequence project expenses
Administration fees
Abstract award
Course expenses
Stationery and printing
Rent payable under operating leases
Support costs for charitable activities
Insurance
Subscriptions
Telephone and internet
IT support and costs
Bookkeeping fees
Project fees
Sundry expenses
Patient Partner expenses
Other professional fees		 Current year
Unrestricted
Funds
2023
£
99		 Current year
Restricted
Funds
2023
£
-
-
Current year
Restricted
Funds
2023
£
-
-
-
-
-
45,000
45,000
Current year
Restricted
Funds
2023
£
-
-
-
-
-
-
-
-
-
-
-		 Current year
Total Funds
2023
£
99
99
Current year
Total Funds
2023
£
4,328
600
-
2,242
9,542
45,000
61,712
Current year
Total Funds
2023
£
1,850
216
138
150
608
293
10
830
-
96
4,191		 Prior Year
Total Funds
2022
£
-
99 -
Prior Year
Total Funds
2022
£
2,849
500
23,104
6,290
6,769
-
16,712 39,512
Current year
Unrestricted
Funds
2023
£
1,850
216
138
150
608
293
10
830
-
96		 Prior Year
Total Funds
2022
£
1,850
222
121
121
688
263
-
1,004
1,532
96
4,191 5,897

17

British Psoriatic Arthritis Consortium

Detailed analysis of income and expenditure for the year ended 31 March 2023 as required by the SORP 2015

19 Other Expenditure - Governance costs

Current Year
Independent Examiner's fees
Total Governance costs		 Current year
Unrestricted
Funds
2023
£
1,642		 Current year
Restricted
Funds
2023
£
-
-		 Current year
Total Funds
2023
£
1,642
1,642		 Prior Year
Total Funds
2022
£
1,170
1,642 1,170

All the expenditure in the prior year was unrestricted.

20 Total Charitable expenditure

Current Year
Total direct spending
B2a
Total support costs
B2d
Total Governance costs
B2e
Total charitable expenditure
B2		 Current year
Unrestricted
Funds
2023
£
16,712
4,191
1,642		 Current year
Restricted
Funds
2023
£
45,000
-
-
45,000		 Current year
Total Funds
2023
£
61,712
4,191
1,642
67,545		 Prior Year
Total Funds
2022
£
39,512
5,897
1,170
22,545 46,579

All the expenditure in the prior year was unrestricted.

Prior Year
Total direct spending
B2a
Total support costs
B2d
Total Governance costs
B2e
Total charitable expenditure
B2		 Prior Year
Unrestricted
Funds
2022
£
39,512
5,897
1,170		 Prior Year
Prior Year
Restricted
Funds
Total Funds
2022
2022
£
£
-
39,512
-
5,897
-
1,170
46,579 -
46,579

18